Cargando…
Lipocalin-2 in Stroke
Stroke is a leading cause of adult disability in the United States. However, limited number of molecularly targeted therapy exists for stroke. Recent studies have shown that Li-pocalin-2 (LCN2) is an acute phase protein mediating neuroinflammation after ischemic and hemorrhagic strokes. This review...
Autores principales: | Chou, Wen-Hai, Wang, Guona, Kumar, Varun, Weng, Yi-Chinn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287915/ https://www.ncbi.nlm.nih.gov/pubmed/30542675 http://dx.doi.org/10.17140/NOJ-2-109 |
Ejemplares similares
-
Identification of lipocalin-2 as a PKCδ phosphorylation substrate in neutrophils
por: Weng, Yi-Chinn, et al.
Publicado: (2015) -
Neutralization of Lipocalin-2 Diminishes Stroke-Reperfusion Injury
por: Wang, Guona, et al.
Publicado: (2020) -
Lipocalin-2 released in response to cerebral ischaemia mediates reperfusion injury in mice
por: Wang, Guona, et al.
Publicado: (2015) -
Lipocalin-2 and Cerebral Stroke
por: Luo, Chao, et al.
Publicado: (2022) -
PKCε phosphorylation regulates the mitochondrial translocation of ATF2 in ischemia-induced neurodegeneration
por: Kumar, Varun, et al.
Publicado: (2018)